Farringdon Capital, Ltd. Novo Nordisk A S Transaction History
Farringdon Capital, Ltd.
- $393 Billion
- Q3 2025
A detailed history of Farringdon Capital, Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 12,196 shares of NVO stock, worth $591,018. This represents 0.17% of its overall portfolio holdings.
Number of Shares
12,196Holding current value
$591,018% of portfolio
0.17%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,693Shares Held
303MCall Options Held
25.9MPut Options Held
43.8M-
Capital International Investors Los Angeles, CA17.7MShares$858 Million0.17% of portfolio
-
Loomis Sayles & CO L P16.2MShares$783 Million1.1% of portfolio
-
Franklin Resources Inc San Mateo, CA14MShares$678 Million0.21% of portfolio
-
Bank Of America Corp Charlotte, NC13.4MShares$650 Million0.05% of portfolio
-
Morgan Stanley New York, NY12.4MShares$602 Million0.04% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $109B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...